{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:19:54Z","timestamp":1782328794016,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.annonc.2023.09.3101","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T01:01:29Z","timestamp":1695258089000},"page":"1165-1174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective"],"prefix":"10.1016","volume":"34","author":[{"given":"S.D.","family":"Foss\u00e5","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.S.","family":"Haugnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Kiserud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Foss\u00e5","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Skalleberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.\u00c5.","family":"Myklebust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annonc.2023.09.3101_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012390","article-title":"Recent global trends in testicular cancer incidence and mortality","volume":"97","author":"Park","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annonc.2023.09.3101_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1200\/JOP.2016.011411","article-title":"Salvage therapy for patients with germ cell tumor","volume":"12","author":"Rashdan","year":"2016","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.annonc.2023.09.3101_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000489135","article-title":"The role of salvage high-dose chemotherapy in relapsed male germ cell tumors","volume":"41","author":"Oing","year":"2018","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.annonc.2023.09.3101_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/PROM.S242754","article-title":"Patient-reported outcomes associated with treatments for testicular cancer: a systematic review","volume":"12","author":"Mercieca-Bebber","year":"2021","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.annonc.2023.09.3101_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41585-021-00440-w","article-title":"Late adverse effects and quality of life in survivors of testicular germ cell tumour","volume":"18","author":"Chovanec","year":"2021","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8671832","article-title":"Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors","volume":"2018","author":"Fung","year":"2018","journal-title":"Adv Urol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib7","first-page":"645","article-title":"Health-related quality of life and psychosocial implications in testicular cancer survivors. A literature review","volume":"22","author":"Cappuccio","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.annonc.2023.09.3101_bib8","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1200\/JCO.2008.19.6931","article-title":"Health-related quality of life in long-term survivors of testicular cancer","volume":"27","author":"Rossen","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib9","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/cncr.24981","article-title":"Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer","volume":"116","author":"Glendenning","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.annonc.2023.09.3101_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11764-020-00944-1","article-title":"Long-term neurotoxicity and quality of life in testicular cancer survivors\u2014a nationwide cohort study","volume":"15","author":"Lauritsen","year":"2021","journal-title":"J\u00a0Cancer Surviv"},{"key":"10.1016\/j.annonc.2023.09.3101_bib11","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer","volume":"34","author":"Frisina","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib12","doi-asserted-by":"crossref","first-page":"E515","DOI":"10.1002\/lary.28543","article-title":"The relationship between cisplatin-related and age-related hearing loss during an extended follow-up","volume":"130","author":"Skalleberg","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.annonc.2023.09.3101_bib13","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2017.77.0735","article-title":"Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study","volume":"36","author":"Kerns","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101744","article-title":"Risk of positive selection bias in longitudinal surveys among cancer survivors: lessons learnt from the National Norwegian Testicular Cancer Survivor Study","volume":"67","author":"Foss\u00e5","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11136-017-1684-4","article-title":"Norwegian reference values for the Short-Form Health Survey 36: development over time","volume":"27","author":"Jacobsen","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.annonc.2023.09.3101_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.annonc.2023.09.3101_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","article-title":"Development of a fatigue scale","volume":"37","author":"Chalder","year":"1993","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.annonc.2023.09.3101_bib18","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/ije\/dys095","article-title":"Cohort profile: the HUNT Study, Norway","volume":"42","author":"Krokstad","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A\u00a012-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"10.1016\/j.annonc.2023.09.3101_bib20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0895-4356(98)00109-7","article-title":"Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment","volume":"51","author":"Gandek","year":"1998","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1365-2036.2009.03966.x","article-title":"Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn\u2019s disease","volume":"29","author":"Coteur","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.annonc.2023.09.3101_bib22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s11136-005-5370-6","article-title":"Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors","volume":"15","author":"Oldenburg","year":"2006","journal-title":"Qual Life Res"},{"key":"10.1016\/j.annonc.2023.09.3101_bib23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","article-title":"The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20","volume":"41","author":"Postma","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annonc.2023.09.3101_bib24","first-page":"741","article-title":"Psychometric evaluation of the Functional Assessment of Cancer Therapy\/Gynecologic Oncology Group-Neurotoxicity (Fact\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy","volume":"13","author":"Calhoun","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.annonc.2023.09.3101_bib25","first-page":"1361","article-title":"Toxic Neuropathy Consortium (TNC). Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings","volume":"90","author":"Argyriou","year":"2019","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.annonc.2023.09.3101_bib26","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jamaneurol.2018.0963","article-title":"Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer: clinical, neurophysiological, functional, and patient-reported outcomes","volume":"75","author":"Kandula","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2014.10.014","article-title":"Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms?","volume":"596","author":"Carozzi","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.annonc.2023.09.3101_bib28","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1158\/1078-0432.CCR-19-0113","article-title":"Clinical and genome-wide analysis of serum platinum levels after cisplatin-based chemotherapy","volume":"25","author":"Trendowski","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annonc.2023.09.3101_bib29","first-page":"1619","article-title":"Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study","volume":"35","author":"Hjelle","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.annonc.2023.09.3101_bib30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/jdi.12650","article-title":"Peripheral neuropathy in prediabetes and the metabolic syndrome","volume":"8","author":"Stino","year":"2017","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.annonc.2023.09.3101_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bcp.12912","article-title":"Drug-induced Raynaud\u2019s phenomenon: beyond \u03b2-adrenoceptor blockers","volume":"82","author":"Khouri","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-100-5-770_2","article-title":"Bleomycin and Raynaud\u2019s phenomenon","volume":"100","author":"Adoue","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annonc.2023.09.3101_bib33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7326\/0003-4819-95-3-288","article-title":"Raynaud\u2019s phenomenon: a common toxicity after combination chemotherapy for testicular cancer","volume":"95","author":"Vogelzang","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annonc.2023.09.3101_bib34","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3390\/antiox10121919","article-title":"Oxidative stress and inflammation caused by cisplatin ototoxicity","volume":"10","author":"Ramkumar","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.annonc.2023.09.3101_bib35","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1200\/JCO.22.01456","article-title":"Patient-reported functional impairment due to hearing loss and tinnitus after cisplatin-based chemotherapy","volume":"41","author":"Sanchez","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib36","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1159\/000527930","article-title":"Hearing loss and cognitive function in early old age: comparing subjective and objective hearing measures","volume":"69","author":"Hoff","year":"2023","journal-title":"Gerontology"},{"key":"10.1016\/j.annonc.2023.09.3101_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.annonc.2023.09.3101_bib38","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/ijerph14101139","article-title":"WHO Environmental Noise Guidelines for the European Region: a systematic review on environmental noise and permanent hearing loss and tinnitus","volume":"14","author":"\u015aliwi\u0144ska-Kowalska","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.annonc.2023.09.3101_bib39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11764-022-01314-9","article-title":"The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review","volume":"17","author":"Phillips","year":"2023","journal-title":"J\u00a0Cancer Surviv"},{"key":"10.1016\/j.annonc.2023.09.3101_bib40","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","article-title":"National comprehensive cancer network. Cancer-Related Fatigue, Version 2.2015","volume":"13","author":"Berger","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.annonc.2023.09.3101_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11864-020-0707-5","article-title":"Cancer-related fatigue: causes and current treatment options","volume":"21","author":"Thong","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3999(97)00291-2","article-title":"Fatigue in the general Norwegian population: normative data and associations","volume":"45","author":"Loge","year":"1998","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.annonc.2023.09.3101_bib43","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1200\/JCO.2005.09.936","article-title":"Fatigue in long-term Hodgkin\u2019s disease survivors: a follow-up study","volume":"23","author":"Hjermstad","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib44","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S1470-2045(16)30093-6","article-title":"Cancer-related fatigue in patients with and survivors of Hodgkin\u2019s lymphoma: a longitudinal study of the German Hodgkin Study Group","volume":"17","author":"Kreissl","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.urolonc.2015.09.005","article-title":"Age-related variation and predictors of long-term quality of life in germ cell tumor survivors","volume":"34","author":"Hartung","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1200\/JCO.2002.20.1.73","article-title":"Quality of life in long-term survivors of testicular cancer: a population-based case-control study","volume":"20","author":"Joly","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00520-005-0879-3","article-title":"Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events","volume":"14","author":"Fleer","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.annonc.2023.09.3101_bib48","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s11136-011-9907-6","article-title":"Quality of life among testicular cancer survivors: a case-control study in the United States","volume":"20","author":"Kim","year":"2011","journal-title":"Qual Life Res"},{"key":"10.1016\/j.annonc.2023.09.3101_bib49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.annonc.2022.01.002","article-title":"Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oldenburg","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib50","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1200\/JCO.21.02105","article-title":"Mortality and second cancer incidence after treatment for testicular cancer: psychosocial health and lifestyle are\u00a0modifiable prognostic factors","volume":"40","author":"Foss\u00e5","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib51","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s11136-021-03028-4","article-title":"Response Shift-in Sync Working Group. Progress in response-shift research needs diverse approaches","volume":"30","author":"Sprangers","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.annonc.2023.09.3101_bib52","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1080\/02841860902795232","article-title":"The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors","volume":"48","author":"Grov","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib53","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2005.08.048","article-title":"Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer","volume":"23","author":"Mykletun","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib54","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/iju.15039","article-title":"Association of financial toxicity with quality of life in testicular cancer survivors","volume":"29","author":"Nezu","year":"2022","journal-title":"Int J Urol"},{"key":"10.1016\/j.annonc.2023.09.3101_bib55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/cancers13030553","article-title":"Identifying the need to discuss infertility concerns affecting testicular cancer patients: an evaluation (INDICATE Study)","volume":"13","author":"Krouwel","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.annonc.2023.09.3101_bib56","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00345-016-1941-0","article-title":"High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how","volume":"35","author":"Lorch","year":"2017","journal-title":"World J Urol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375342303939X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375342303939X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T01:02:12Z","timestamp":1733014932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375342303939X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S092375342303939X"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2023.09.3101","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2023.09.3101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society for Medical Oncology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}